Welcome to The Dose, which tackles the business and economics inside the turbulent world of health care and life sciences in Indiana. Your host is John Russell. To contact me call 317-472-5383.
Medical office buildings, traditionally a low-key sector of the real-estate market, are getting plenty of attention these days, with recent big-dollar deals from Indianapolis players Duke Realty and Cornerstone Cos.
An embattled industry is pushing back against complaints of high drug prices, constant drug advertising and companies that don't invest enough in research. Here's a Q&A with Stephen Ubl, CEO of the industry's trade group.
The West Lafayette-based biotech firm once was seen as a rising star with a pipeline that could save cancer patients. Now, 20 years after its founding, without a single launch, it is laying off 40 percent of its workforce.
The small Johnson County college has turned out its share of science graduates over the decades, and says the expansion will continue to attract students.
The acquisition of the Premier Healthcare physician group and the groundbreaking of a $340 million hospital on the IU campus will give the Indianapolis-based health system a stronger foothold in Bloomington.
Physicians use electronic health records all day long. How will medical students learn about them? The AMA is rolling out a new program developed in Indianapolis.
News that federal regulators rejected Lilly's drug for arthritis sent the stock tumbling more than 5 percent Monday, and sent surprised analysts searching for answers.